Investor Sues Drug Maker, Others Over Alleged IPO Misstatements
(December 10, 2015, 11:14 AM EST) -- LOS ANGELES — A shareholder filed a securities class action complaint in California state court on Dec. 1, alleging that a clinical-stage biopharmaceutical company and certain of its executive officers misrepresented the Phase III clinical study results for a colorectal cancer drug it was developing in violation of federal securities laws (Yogina Rezko v. XBiotech Inc., et al., No. BC602793, Calif. Super., Los Angeles Co.).
(Complaint available. Document #57-151214-501C.)
Shareholder Yogina Rezko filed a securities class action complaint in the Los Angeles County Superior Court on...